Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study). - Okai, Annette F.; Amezcua, Lilyana; Berkovich, Regina R.; Chinea, Angel R.; Edwards, Keith R.; Steingo, Brian; Walker, Aljoeson; Jacobs, Alan K.; Daizadeh, Nadia; Williams, Mitzi J. (Neurology & Therapy, 2019)